Defining molecular mechanisms underlying the pathogenesis of APL and therapy-related leukaemias

Project: Research

Project Details

StatusFinished
Effective start/end date1/12/201330/11/2018

Collaborative partners

Funding

  • Blood Cancer UK: £1,351,762.00